Citadel Advisors (Ken Griffin) — BMRN Trade History
Quarter-by-quarter changes in the BIOMARIN PHARMACEUTICAL INC position · CUSIP 09061G101
Currently held · 4.5 YearsFirst seen: 2015 Q4
| Quarter | Filed | Activity | Shares | Δ Shares | Δ % | Value | % Port. |
|---|---|---|---|---|---|---|---|
| 2026 Q2 | 2026-09-02 | Reduce | 1,122,408 | -3,390,226 | -75.1% | $64.2M | 0.01% |
| 2026 Q1 | 2026-05-15 | Add | 4,512,634 | 3,147,943 | +230.7% | $254.9M | 0.04% |
| 2025 Q4 | 2026-02-17 | Add | 1,364,691 | 966,844 | +243.0% | $81.1M | 0.01% |
| 2025 Q3 | 2025-11-14 | Add | 397,847 | 62,827 | +18.8% | $21.5M | 0.00% |
| 2025 Q2 | 2025-08-14 | Reduce | 335,020 | -1,260,038 | -79.0% | $18.4M | 0.00% |
| 2025 Q1 | 2025-05-15 | Add | 1,595,058 | 1,207,445 | +311.5% | $112.8M | 0.02% |
| 2024 Q4 | 2025-02-14 | Reduce | 387,613 | -816,784 | -67.8% | $25.5M | 0.00% |
| 2024 Q3 | 2024-11-14 | Add | 1,204,397 | 646,545 | +115.9% | $84.7M | 0.02% |
| 2024 Q2 | 2024-08-14 | Reduce | 557,852 | -1,417,706 | -71.8% | $45.9M | 0.01% |
| 2024 Q1 | 2024-05-15 | Add | 1,975,558 | 1,620,613 | +456.6% | $172.5M | 0.03% |
| 2023 Q4 | 2024-02-14 | Add | 354,945 | 213,413 | +150.8% | $34.2M | 0.01% |
| 2023 Q3 | 2023-11-14 | Reduce | 141,532 | -340,807 | -70.7% | $12.5M | 0.00% |
| 2023 Q2 | 2023-08-14 | Add | 482,339 | 358,771 | +290.3% | $41.8M | 0.01% |
| 2023 Q1 | 2023-05-15 | Reduce | 123,568 | -6,933 | -5.3% | $12.0M | 0.00% |
| 2022 Q4 | 2023-02-14 | Reduce | 130,501 | -871,813 | -87.0% | $13.5M | 0.00% |
| 2022 Q3 | 2022-11-14 | Reduce | 1,002,314 | -150,761 | -13.1% | $85.0M | 0.02% |
| 2022 Q2 | 2022-08-15 | Reduce | 1,153,075 | -937,328 | -44.8% | $95.6M | 0.03% |
| 2022 Q1 | 2022-05-16 | New | 2,090,403 | 2,090,403 | — | $161.2M | 0.03% |
| 2021 Q3 | 2022-03-11 | Sold out | — | -1,357,915 | -100.0% | — | — |
| 2021 Q4 | 2022-02-14 | Add | 1,357,915 | 397,753 | +41.4% | $120.0M | 0.03% |
| 2021 Q2 | 2021-08-16 | Reduce | 960,162 | -673,518 | -41.2% | $80.1M | 0.02% |
| 2021 Q1 | 2021-05-21 | Reduce | 1,633,680 | -1,361,590 | -45.5% | $123.4M | 0.03% |
| 2020 Q4 | 2021-02-16 | Add | 2,995,270 | 517,914 | +20.9% | $262.7M | 0.07% |
| 2020 Q3 | 2020-11-16 | Add | 2,477,356 | 2,222,384 | +871.6% | $188.5M | 0.05% |
| 2020 Q2 | 2020-08-14 | Reduce | 254,972 | -4,355 | -1.7% | $31.4M | 0.01% |
| 2020 Q1 | 2020-05-15 | Reduce | 259,327 | -1,780,826 | -87.3% | $21.9M | 0.01% |
| 2019 Q4 | 2020-02-14 | New | 2,040,153 | 2,040,153 | — | $172.5M | 0.07% |
| 2019 Q2 | 2020-02-14 | — | — | — | — | — | — |
| 2018 Q4 | 2019-11-14 | Sold out | — | -1,757,230 | -100.0% | — | — |
| 2019 Q3 | 2019-11-14 | New | 1,757,230 | 1,757,230 | — | $118.4M | 0.06% |
| 2018 Q2 | 2019-08-14 | — | — | — | — | — | — |
| 2018 Q3 | 2019-05-15 | Sold out | — | -1,128,648 | -100.0% | — | — |
| 2019 Q1 | 2019-05-15 | New | 1,128,648 | 1,128,648 | — | $100.3M | 0.05% |
| 2018 Q1 | 2019-02-14 | Sold out | — | -2,315,075 | -100.0% | — | — |
| 2017 Q4 | 2018-02-09 | Add | 2,315,075 | 671,639 | +40.9% | $206.4M | 0.13% |
| 2017 Q3 | 2017-11-09 | Add | 1,643,436 | 1,401,415 | +579.0% | $153.0M | 0.12% |
| 2017 Q2 | 2017-08-11 | Reduce | 242,021 | -224,884 | -48.2% | $22.0M | 0.02% |
| 2017 Q1 | 2017-05-12 | Reduce | 466,905 | -233,832 | -33.4% | $41.0M | 0.04% |
| 2016 Q4 | 2017-02-10 | Add | 700,737 | 627,320 | +854.5% | $58.0M | 0.06% |
| 2015 Q4 | 2017-01-31 | New | 73,417 | 73,417 | — | $7.7M | 0.01% |
Share counts are split-adjusted. Time held counts consecutive quarters ending with the latest filing; more than ten years shows as ">10 Years".
13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.